High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.

Abstract

Newborn screening for congenital adrenal hyperplasia (CAH) is justified by the sometimes difficult clinical diagnosis and the risks associated with missed diagnosis, particularly the life-threatening salt-wasting crisis. In Switzerland, nationwide screening for CAH by measuring 17-hydroxyprogesterone levels in dried blood spots was introduced in 1992. At… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.